No impact of IL28B polymorphisms on liver enzymes in patients coinfected with HIV and HCV

Results A total of 124 patients (44% normal ALT levels, median age 42 years, 68% males, 93% IDUs, 33% alcohol abuse, 5% HBsAg+, median CD4 count 511 cells/μL, median serum HCV-RNA 6.05 log10 copies/mL, 62% HCV genotype 1) were analyzed. Overall 34% of the whole population displayed the IL-28B CC genotype. When comparing ALT groups, 18 (32.7%) with normal ALT showed CC vs 25 (36.2%) with elevated ALT (p=0.71). Using elastometry (FibroScan), liver fibrosis estimates were significantly lower at baseline in patients with normal vs elevated ALT (6.3±2 vs 14.4±12 kPa, respectively, p<0.001). Other differences amongst groups were not significant, as follows: baseline serum HCV-RNA (5.95 vs 6.05 log10 IU/ mL, p=0.62), CD4 counts (499 vs 543 cells/μl, p=0.34), and prothrombin activity (91% in both groups, p=0.99). Patients with normal vs elevated ALT were found to be coinfected more frequently with HCV genotypes 1 or 4 (45% vs 26%, p=0.02). Conclusions IL28B genotypes do not influence ALT levels in HIVHCV coinfected patients. Higher ALT levels are associated with a greater extent of liver fibrosis.